...
首页> 外文期刊>Journal of cataract and refractive surgery >Photorefractive keratectomy or laser in situ keratomileusis for residual refractive error after phakic intraocular lens implantation.
【24h】

Photorefractive keratectomy or laser in situ keratomileusis for residual refractive error after phakic intraocular lens implantation.

机译:有晶状体人工晶状体植入术后残留屈光不正的光折射角膜切除术或激光原位角膜磨镶术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To evaluate the results of combining phakic posterior chamber intraocular lens (IOL) implantation and excimer corneal surgery to treat high myopia or myopia with astigmatism.Service d'Ophtalmologie, Hopital Purpan, University of Toulouse, Toulouse, France.Thirty-two eyes of 28 patients with extreme myopia or myopia combined with astigmatism were treated by implantation of a phakic posterior chamber IOL. Residual refractive errors were treated no earlier than 6 weeks after IOL implantation by photorefractive keratectomy (PRK) in eyes with low refractive errors or by laser in situ keratomileusis (LASIK) in eyes with higher residual refractive errors.The mean preoperative spherical equivalent (SE) refraction was -18.7 diopters (D). The refractive astigmatism ranged from 0 to 3.5 D. After excimer laser treatment, the SE refraction ranged from -0.5 to -2.5 D and the refractive astigmatism, from 0 to 1.5 D in the PRK group. In the LASIK group, spherical ametropia ranged from -1.5 to +1.5 D and astigmatism, from 0 to 1.0 D. After excimer laser treatment, the uncorrected visual acuity improved in all eyes but a loss of 1 line of the corrected vision after IOL implantation occurred in 22.2% of PRK-treated eyes and in 13.6% of LASIK-treated eyes.Bioptic treatment of extreme myopia and myopia associated with astigmatism appears to be safer and more predictable than other methods of treatment.
机译:评估有晶状体后房型人工晶状体(IOL)植入与准分子角膜矫正术相结合治疗高度近视或近视合并散光的结果。法国图卢兹图卢兹大学霍普塔尔·普尔潘服务眼科医师32眼28高度近视或近视合并散光的患者通过植入有晶状体后房人工晶体治疗。在屈光度低的眼中进行光折光性角膜切除术(PRK)或在残余屈光度较高的眼中通过激光原位角膜磨镶术(LASIK)进行IOL植入后不超过6周的残余屈光不正。屈光度为-18.7屈光度(D)。准分子激光治疗后,屈光散光范围为0至3.5D。在PRK组中,SE屈光度范围为-0.5至-2.5 D,屈光散光范围为0至1.5D。在LASIK组中,球面屈光不正介于-1.5至+1.5 D之间,散光的范围介于0至1.0 D之间。准分子激光治疗后,所有眼睛的未矫正视力均得到改善,但IOL植入后矫正视力损失了1行在接受PRK治疗的眼睛中有22.2%发生了这种情况,而在接受LASIK治疗的眼睛中有13.6%发生了这种情况。极端近视和与散光相关的近视的活检似乎比其他治疗方法更安全,更可预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号